Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2025-06-09 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
马应龙关于续聘2025年度会计师事务所的议案
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (中审众环会计师事务所) for the 2025 fiscal year audit. It details the qualifications, integrity, and independence of the accounting firm and the procedures followed by the audit committee and board of directors to approve the reappointment. There are no actual financial statements or audit results included, only information about the appointment process and firm credentials. The document is relatively short (2517 characters) and serves as a formal announcement rather than the audit report itself. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or financial statement filing. FY 2025
2025-06-09 Chinese
马应龙关于召开2024年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of Mayinglong Pharmaceutical Group Co., Ltd. It includes information about the meeting date, voting methods, agenda items including the 2024 annual report and financial statements, shareholder voting procedures, and proxy authorization. The document does not contain the actual annual report or financial statements but rather the announcement and details for shareholders to participate in the AGM. The document length is 3347 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2025-06-09 Chinese
马应龙关于全资子公司获得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about its wholly-owned subsidiary receiving a drug registration certificate from the National Medical Products Administration. It details the drug's specifications, approval, market data, and potential impact on the company. The document is short (1257 characters) and serves as an official announcement rather than a detailed financial or operational report. It does not contain financial statements, management discussion, or regulatory certifications. It is not a report of voting results, nor a call transcript or capital update. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a material event related to the company but does not fit other specific categories.
2025-06-09 Chinese
马应龙第十一届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from the company 马应龙药业集团股份有限公司. It details the decisions made at the 20th meeting of the 11th board, including the proposal to reappoint the accounting firm for the 2025 audit and the plan to hold the 2024 annual shareholders meeting. The document references other announcements for detailed information and does not contain financial statements or detailed financial data itself. It is a formal announcement of board decisions rather than a full management report or audit report. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2025-06-09 Chinese
马应龙关于参加湖北辖区上市公司2025年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor collective reception day event organized by regulatory and industry bodies. It mentions the date and format of the event and invites investors to participate. There is no financial data, no report attached or published, and no detailed presentation or transcript included. The document is a regulatory announcement informing the public about an upcoming investor interaction event, not a report or transcript itself. Given the nature and content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-06-06 Chinese
马应龙关于控股股东部分股份解除质押的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the release of a portion of pledged shares by the controlling shareholder of the company. It details the number of shares released from pledge, the remaining pledged shares, and the shareholder's total holdings. There is no financial report, earnings data, or management discussion. The content focuses on share pledge status, which relates to share transactions by major shareholders or insiders. This fits the category of Transaction in Own Shares (POS), as it reports on changes in share pledges by a controlling shareholder, which is a form of share transaction disclosure.
2025-05-29 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.